BCAL Diagnostics Ltd
BCAL Diagnostics Limited is an Australia-based biotechnology company.
The business
BCAL Diagnostics Limited is an Australia-based biotechnology company. The Company develops early, non-invasive blood test-based diagnostic technologies designed to complement mammograms and improve breast cancer screening outcomes. Its commercial laboratory, equipped with Liquid Chromatography Mass Spectrometry (LCMS) technology, is focused on scientific innovation and clinical service delivery, supporting both ongoing research and the commercial rollout of our diagnostic test. The Company develops a blood test for breast cancer screening and diagnosis. The assay measures a panel of lipids in blood plasma using Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS). Its lipid measurements are converted to a test score using a proprietary diagnostic algorithm. It offers BREASTEST plus, which is a blood test designed to be used alongside a mammogram in breast cancer screening. It provides information for women with dense breasts to help rule out the presence of breast cancer.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news
ASX Investment Opportunities on Show in Singapore During Grand Prix
All roads will lead to Singapore in early October with the important Spark Plus Aussie Equities Day investment show being staged in the lead-up to the local grand prix motoring event. The 2025 Spark Plus Aussie Equities Day is the 4th installment of their flagship event which aims to introduce a range of Australian companies to […]
BCAL Diagnostics launches groundbreaking blood test to aid early detection of breast cancer
BCAL Diagnostics (ASX: BDX) has launched a first-in-class blood test known as BREASTEST plus to address the challenge of high breast density, which can impact standard-of-care breast cancer screening practices. The company designed the lipid test for use alongside traditional mammogram imaging and it has been validated to meet the challenge of high breast density, […]
Market wrap: local factors push Australian stocks higher
While international influences such as the surprise jump in US bond yields had a big impact on the Australian share market overall, local factors also played a big part in some significant price volatility in many individual shares. By the close of trade on Friday the ASX 200 managed to reverse an earlier fall to […]
BCAL Diagnostics takes major step forward in commercialising blood test for breast cancer screening
Australian biotechnology company BCAL Diagnostics (ASX: BDX) has announced breakthrough results from a clinical study of its non-invasive blood-based test for detecting early-stage breast cancer. Sponsored by US commercialisation partner Precion Inc, the study achieved a test sensitivity rating of 90% and a specificity of 85.5%, both of which were consistent with the findings of […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.